Isomorphic Labs

Today we share a technical report demonstrating how our drug design engine achieves a step-change in accuracy for predicting biomolecular structures, more than doubling the performance of AlphaFold 3 on key benchmarks and unlocking rational drug design even for examples it has never seen before. Head to the comments to read our blog.

@KubeCon_ bit.ly/4bjDdKy

We’re heading to @KubeCon_ from 23–26 March 📍 Our engineering group is growing across ML Platform, Compute Infrastructure and TechOps in London and Lausanne. If you want to use your skills to rethink drug design and have a real impact on human health, they’d love to meet you. Check the comments for the registration link.

@iclr_conf rsvp.withgoogle.com/events/isomorp…

We’re heading to @iclr_conf to meet exceptional Machine Learning Engineers, ML Research Engineers and ML Research Scientists at all levels to join us in London and Lausanne. If you want to solve problems that have a tangible impact on human health alongside a brilliant team, we would really like to meet you. Check the comments for the link to apply. See you in Rio!

“It’s exciting to work side by side with our ML researchers to solve drug discovery challenges that used to feel out of reach.” Simon Richards, Director of Computational Drug Design Our Computational Drug Designers are at the heart of our transformative research, using our drug design engine to develop promising new medicines at a pace once thought impossible. We’re hiring Computational Drug Designers at all levels, see our latest roles here: bit.ly/424SMjZ

“One of the great things about Iso is how interdisciplinary everyone is, people come from so many different backgrounds.” We spoke with Bilal Khan, Software Engineer at @IsomorphicLabs, about our unique, collaborative culture and frontier AI built to tackle the world's most complex problems. Watch the video and head to the comments to explore our current roles.

We recently released a technical report highlighting how @IsomorphicLabs’ drug design engine is achieving a step change in how we model complex biological mechanisms, consistently outperforming industry benchmarks. Read our blog to discover how we’re bridging the gap between structure prediction and rational drug design. You can find the link in the comments.

“What I’ve always dreamed about doing, and the first thing I wanted to apply AI to was human health... What could be a more important use of AI.” @demishassabis sat down with @ajs for a new episode of @Fortune500: Titans and Disruptors of Industry to discuss his vision behind founding Isomorphic Labs, and how our interdisciplinary team is moving closer to solving all disease. youtube.com/watch?v=BhfTQX…

Brilliant to see @Nature highlighting the power of @IsomorphicLabs’ generalisable drug design engine. @ewencallaway explores how it achieves high precision in predicting how proteins interact with potential drugs and antibody structures, even in cases that sit far outside its training data. Read the full piece here: nature.com/articles/d4158…

“I think eventually, over the next 10 to 20 years, we could get to finding a solution to all disease…if we have a process that can find these needles in a haystack.” Isomorphic Labs Founder and CEO @DemisHassabis and the team took @FortuneMagazine’s @Agarfinks behind the scenes to see how it uses Iso’s drug design engine to sort through near-infinite chemical possibilities to find the right compound for a disease. The story captures the exciting momentum inside our doors right now, and our team's shared drive to shape the next chapter of medicine. fortune.com/article/demis-…

Earlier this week, we revealed the exciting progress we’ve been making at @IsomorphicLabs. Here, our President, @maxjaderberg, explains the significance of our breakthroughs and how they are reshaping the future of drug discovery. Check out his thread for more 🧵

Read our blog to find out more bit.ly/4a6KL2G

Today we share a technical report demonstrating how our drug design engine achieves a step-change in accuracy for predicting biomolecular structures, more than doubling the performance of AlphaFold 3 on key benchmarks and unlocking rational drug design even for examples it has never seen before. Head to the comments to read our blog.

@appliedmldays bit.ly/4ruDXS5

If you are heading to the @appliedmldays Intelligence Summit next week, don’t miss James Kirkpatrick’s keynote exploring the architecture of Isomorphic Labs’ drug design engine that can perform tasks bridging the gap between structure prediction and developing new potential medicines. Head to the comments to register.

Take a look at our open roles here: bit.ly/424SMjZ

We sat down with Research Investigator, André Shamsabadi, to hear how his curiosity and passion for working at the cutting edge of science and technology led him to @IsomorphicLabs. He told us: “For me it feels less like a job and more like a hobby...It's pure exploration, it’s completely pushing the boundaries and entering into the unknown.” Watch Andre's story and head to the comments section for a link to our current roles.

@JNJInnovation Read more here: bit.ly/4b2WRL2

@IsomorphicLabs today announced a cross-modality and multi-target research collaboration with @JNJInnovation. The partnership brings together Isomorphic’s AI-first approach to drug design with Johnson & Johnson’s expertise in drug discovery to design novel molecules that might otherwise remain undiscovered. Head to the comments for the full announcement.